Skip to main content
Log in

ABV “most rational” option for Kaposi's sarcoma in Brazil

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Vanni TM, Fonseca BAL, Polanczyk CA.Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil. HIV Clinical Trials 7: 194-202, No. 4, Jul-Aug 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ABV “most rational” option for Kaposi's sarcoma in Brazil. Pharmacoecon. Outcomes News 518, 5 (2006). https://doi.org/10.2165/00151234-200605180-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00016

Keywords

Navigation